Serum markers of hepatocellular carcinoma

Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Massimiliano Berretta, Alessandro Cappellani, Mariano Malaguarnera

Research output: Contribution to journalArticle

Abstract

Background The hepatocellular carcinoma is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains intricate. Methods A literature search identified potential markers for hepatocellular carcinoma. These markers were analysed and justification was provided for these factors' inclusion to (or exclusion from) the markers of hepatocellular carcinoma (HCC). A search of the literature was made using cancer literature and the PubMed database for the following keywords: "markers and HCC," "Lens culinaris agglutinin reactive AFP (AFP-L3) and HCC," "Des-γ-carboxy prothrombin (DCP) and HCC," "Glypican-3 and HCC," "Chromogranin A and HCC," "Transforming growth factor β1(TGF) and HCC," "α-l-fucosidase (AFU) and HCC," "Golgi protein-73 (GP73) and HCC," "Hepatocyte growth factor (HGF) and HCC," "Nervous growth factor (NGF) and HCC." Conclusions Despite the large number of studies devoted to the immunohistochemistry of HCC, at the present time, the absolute positive and negative markers for HCC are still lacking, and even those characterized by very high sensitivity and specificity do not have an universal diagnostic usefulness. Given the poor response to current therapies, a better understanding of the molecular pathways active in this disease could potentially provide new targets for therapy. However, AFP shows a low sensitivity, therefore other biomarkers have been developed to make an early diagnosis and improve patients' prognosis.

Original languageEnglish
Pages (from-to)2744-2755
Number of pages12
JournalDigestive Diseases and Sciences
Volume55
Issue number10
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Hepatocellular Carcinoma
Biomarkers
Glypicans
alpha-L-Fucosidase
Chromogranin A
Hepatocyte Growth Factor
Transforming Growth Factors
Prothrombin
PubMed
Early Diagnosis
Neoplasms
Intercellular Signaling Peptides and Proteins
Survival Rate
Immunohistochemistry
Databases

Keywords

  • Alfa-l-fucosidase (AFU)
  • Alpha-fetoprotein (AFP)
  • Chromogranin-A(CgA)
  • Des-γ-carboxy prothrombin (DCP)
  • Glypican-3 (GPC3)
  • Golgi protein 73 (GP73)
  • Hepatocellular carcinoma
  • Lens culinaris agglutinin reactive AFP (AFP-L3)
  • Transforming growth factor β1 (TGF-β1)

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Malaguarnera, G., Giordano, M., Paladina, I., Berretta, M., Cappellani, A., & Malaguarnera, M. (2010). Serum markers of hepatocellular carcinoma. Digestive Diseases and Sciences, 55(10), 2744-2755. https://doi.org/10.1007/s10620-010-1184-7

Serum markers of hepatocellular carcinoma. / Malaguarnera, Giulia; Giordano, Maria; Paladina, Isabella; Berretta, Massimiliano; Cappellani, Alessandro; Malaguarnera, Mariano.

In: Digestive Diseases and Sciences, Vol. 55, No. 10, 10.2010, p. 2744-2755.

Research output: Contribution to journalArticle

Malaguarnera, G, Giordano, M, Paladina, I, Berretta, M, Cappellani, A & Malaguarnera, M 2010, 'Serum markers of hepatocellular carcinoma', Digestive Diseases and Sciences, vol. 55, no. 10, pp. 2744-2755. https://doi.org/10.1007/s10620-010-1184-7
Malaguarnera G, Giordano M, Paladina I, Berretta M, Cappellani A, Malaguarnera M. Serum markers of hepatocellular carcinoma. Digestive Diseases and Sciences. 2010 Oct;55(10):2744-2755. https://doi.org/10.1007/s10620-010-1184-7
Malaguarnera, Giulia ; Giordano, Maria ; Paladina, Isabella ; Berretta, Massimiliano ; Cappellani, Alessandro ; Malaguarnera, Mariano. / Serum markers of hepatocellular carcinoma. In: Digestive Diseases and Sciences. 2010 ; Vol. 55, No. 10. pp. 2744-2755.
@article{8b8424e4e98348bcbb20f3c215ebd1c6,
title = "Serum markers of hepatocellular carcinoma",
abstract = "Background The hepatocellular carcinoma is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains intricate. Methods A literature search identified potential markers for hepatocellular carcinoma. These markers were analysed and justification was provided for these factors' inclusion to (or exclusion from) the markers of hepatocellular carcinoma (HCC). A search of the literature was made using cancer literature and the PubMed database for the following keywords: {"}markers and HCC,{"} {"}Lens culinaris agglutinin reactive AFP (AFP-L3) and HCC,{"} {"}Des-γ-carboxy prothrombin (DCP) and HCC,{"} {"}Glypican-3 and HCC,{"} {"}Chromogranin A and HCC,{"} {"}Transforming growth factor β1(TGF) and HCC,{"} {"}α-l-fucosidase (AFU) and HCC,{"} {"}Golgi protein-73 (GP73) and HCC,{"} {"}Hepatocyte growth factor (HGF) and HCC,{"} {"}Nervous growth factor (NGF) and HCC.{"} Conclusions Despite the large number of studies devoted to the immunohistochemistry of HCC, at the present time, the absolute positive and negative markers for HCC are still lacking, and even those characterized by very high sensitivity and specificity do not have an universal diagnostic usefulness. Given the poor response to current therapies, a better understanding of the molecular pathways active in this disease could potentially provide new targets for therapy. However, AFP shows a low sensitivity, therefore other biomarkers have been developed to make an early diagnosis and improve patients' prognosis.",
keywords = "Alfa-l-fucosidase (AFU), Alpha-fetoprotein (AFP), Chromogranin-A(CgA), Des-γ-carboxy prothrombin (DCP), Glypican-3 (GPC3), Golgi protein 73 (GP73), Hepatocellular carcinoma, Lens culinaris agglutinin reactive AFP (AFP-L3), Transforming growth factor β1 (TGF-β1)",
author = "Giulia Malaguarnera and Maria Giordano and Isabella Paladina and Massimiliano Berretta and Alessandro Cappellani and Mariano Malaguarnera",
year = "2010",
month = "10",
doi = "10.1007/s10620-010-1184-7",
language = "English",
volume = "55",
pages = "2744--2755",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Serum markers of hepatocellular carcinoma

AU - Malaguarnera, Giulia

AU - Giordano, Maria

AU - Paladina, Isabella

AU - Berretta, Massimiliano

AU - Cappellani, Alessandro

AU - Malaguarnera, Mariano

PY - 2010/10

Y1 - 2010/10

N2 - Background The hepatocellular carcinoma is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains intricate. Methods A literature search identified potential markers for hepatocellular carcinoma. These markers were analysed and justification was provided for these factors' inclusion to (or exclusion from) the markers of hepatocellular carcinoma (HCC). A search of the literature was made using cancer literature and the PubMed database for the following keywords: "markers and HCC," "Lens culinaris agglutinin reactive AFP (AFP-L3) and HCC," "Des-γ-carboxy prothrombin (DCP) and HCC," "Glypican-3 and HCC," "Chromogranin A and HCC," "Transforming growth factor β1(TGF) and HCC," "α-l-fucosidase (AFU) and HCC," "Golgi protein-73 (GP73) and HCC," "Hepatocyte growth factor (HGF) and HCC," "Nervous growth factor (NGF) and HCC." Conclusions Despite the large number of studies devoted to the immunohistochemistry of HCC, at the present time, the absolute positive and negative markers for HCC are still lacking, and even those characterized by very high sensitivity and specificity do not have an universal diagnostic usefulness. Given the poor response to current therapies, a better understanding of the molecular pathways active in this disease could potentially provide new targets for therapy. However, AFP shows a low sensitivity, therefore other biomarkers have been developed to make an early diagnosis and improve patients' prognosis.

AB - Background The hepatocellular carcinoma is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains intricate. Methods A literature search identified potential markers for hepatocellular carcinoma. These markers were analysed and justification was provided for these factors' inclusion to (or exclusion from) the markers of hepatocellular carcinoma (HCC). A search of the literature was made using cancer literature and the PubMed database for the following keywords: "markers and HCC," "Lens culinaris agglutinin reactive AFP (AFP-L3) and HCC," "Des-γ-carboxy prothrombin (DCP) and HCC," "Glypican-3 and HCC," "Chromogranin A and HCC," "Transforming growth factor β1(TGF) and HCC," "α-l-fucosidase (AFU) and HCC," "Golgi protein-73 (GP73) and HCC," "Hepatocyte growth factor (HGF) and HCC," "Nervous growth factor (NGF) and HCC." Conclusions Despite the large number of studies devoted to the immunohistochemistry of HCC, at the present time, the absolute positive and negative markers for HCC are still lacking, and even those characterized by very high sensitivity and specificity do not have an universal diagnostic usefulness. Given the poor response to current therapies, a better understanding of the molecular pathways active in this disease could potentially provide new targets for therapy. However, AFP shows a low sensitivity, therefore other biomarkers have been developed to make an early diagnosis and improve patients' prognosis.

KW - Alfa-l-fucosidase (AFU)

KW - Alpha-fetoprotein (AFP)

KW - Chromogranin-A(CgA)

KW - Des-γ-carboxy prothrombin (DCP)

KW - Glypican-3 (GPC3)

KW - Golgi protein 73 (GP73)

KW - Hepatocellular carcinoma

KW - Lens culinaris agglutinin reactive AFP (AFP-L3)

KW - Transforming growth factor β1 (TGF-β1)

UR - http://www.scopus.com/inward/record.url?scp=77957892168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957892168&partnerID=8YFLogxK

U2 - 10.1007/s10620-010-1184-7

DO - 10.1007/s10620-010-1184-7

M3 - Article

C2 - 20339916

AN - SCOPUS:77957892168

VL - 55

SP - 2744

EP - 2755

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 10

ER -